Exendin-4 restores glucolipotoxicity-induced gene expression in human coronary artery endothelial cells

Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults

Joseph Yeboah, John R. Crouse, Fang‐Chi Hsu et al. · Circulation · 2007 · 885 citations · Full text

Medicine, Cardiology, Geriatric Medicine +16

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Rüdiger Göke, H. C. Fehmann, Thomas Linn et al. · Journal of Biological Chemistry · 1993 · 838 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Octavio Hernández‐Perera, Dolores Pérez‐Sala, R. Sánchez-Pascuala et al. · Journal of Clinical Investigation · 1998 · 764 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +12

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

Thomas Nyström, M. Gutniak, Qimin Zhang et al. · American Journal of Physiology-Endocrinology and Metabolism · 2004 · 671 citations

Medicine, Cardiology, Endocrinology +17

Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway

Andreas Papapetropoulos, David Fulton, Keyvan Mahboubi et al. · Journal of Biological Chemistry · 2000 · 634 citations · Full text

Life Sciences, Cell Biology, Pathobiology +17